Search Within

Anthony R Mato

Formats
  1. Meeting Abstract (135)
  2. Journal Article (62)
  3. Review (16)
  4. Research Letter (10)
  5. Editorial (7)
  6. Guidelines (3)
  7. Book Section (1)
  8. Miscellaneous (1)
Groups
  1. Adult Leukemia (235)
  2. Center for Hematologic Malignancies (235)
  3. Department of Medicine (235)
  4. Hematologic Malignancies, Division of (235)
  5. Lymphoma (47)
  6. GME, Medicine (32)

More Groups

People
  1. Lindsey Roeker (94)
  2. Andrew Zelenetz (33)
  3. Meghan Thompson (30)
  4. Omar Abdel-Wahab (19)
  5. Maria Palomba (18)
  6. Colleen Dorsey (14)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (22)
  4. 2022 (49)
  5. 2021 (39)
  6. 2020 (52)

More Years

Publications
  1. Blood (82)
  2. Journal of Clinical Oncology (18)
  3. Clinical Lymphoma, Myeloma and Leukemia (16)
  4. Leukemia and Lymphoma (16)
  5. British Journal of Haematology (15)
  6. Blood Advances (10)

More Publications

Publishers
  1. American Society of Hematology (94)
  2. American Society of Clinical Oncology (19)
  3. Elsevier Inc. (18)
  4. Taylor & Francis Group (18)
  5. John Wiley & Sons (16)
  6. American Association for Cancer Research (10)

More Publishers

Results (235)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
    Research Letter

    Roeker, L. E.; Knorr, D. A.; Thompson, M. C.; Nivar, M.; Lebowitz, S.; Peters, N.; Deonarine, I. Jr; Momotaj, S.; Sharan, S.; Chanlatte, V.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • All in the family: Back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
    Editorial

    Thompson, M. C.; Roeker, L. E.; Mato, A. R.
    Haematologica (2021)

    Fulltext@MSK | Save
  • Searching for a home: Phosphoinositide 3-kinase inhibitors for chronic lymphocytic leukaemia in modern clinical practice
    Editorial

    Roeker, L. E.; Thompson, M. C.; Mato, A. R.
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation
    Journal Article

    Lahoud, O. B.; Devlin, S. M.; Maloy, M. A.; Roeker, L. E.; Dahi, P. B.; Ponce, D. M.; Gyurkocza, B.; Koehne, G.; Young, J. W.; Castro-Malaspina, H. R.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Pirtobrutinib (LOXO‐305), a next generation highly selective non‐covalent BTK inhibitor in previously treated richter transformation: Results from the phase 1/2 bruin study
    Meeting Abstract

    Jurczak, W.; Shah, N. N.; Lamanna, N.; Eyre, T. A.; Woyach, J.; Lech‐Maranda, E.; Wierda, W. G.; Lewis, D.; Thompson, M. C.; Wang, D.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Treatment of chronic lymphocytic leukemia after discontinuation of Bruton's tyrosine kinase inhibitors
    Review

    Thompson, M. C.; Mato, A. R.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save
  • Pirtobrutinib (LOXO-305), a next generation highly selective non-covalent Bruton's tyrosine kinase inhibitor in previously treated mantle cell lymphoma and other non-Hodgkin lymphomas: Results from the phase 1/2 BRUIN study
    Meeting Abstract

    Eyre, T.; Shah, N. N.; Alencar, A.; Gerson, J. N.; Patel, M. R.; Fakhri, B.; Jurczak, W.; Tan, X.; Lewis, K.; Fenske, T.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Pirtobrutinib (LOXO-305), a next generation highly selective non-covalent Bruton's tyrosine kinase inhibitor in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the Phase 1/2 BRUIN study
    Meeting Abstract

    Eyre, T.; Pagel, J. M.; Coombs, C. C.; Shah, N. N.; Lamanna, N.; Lech-Maranda, E.; Woyach, J.; Wierda, W. G.; Cheah, C. Y.; Roeker, L.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Real-world prognostic biomarker testing and nursing experience from the prospective observational registry informCLL for patients receiving treatment for chronic lymphocytic leukemia/small lymphocytic lymphoma
    Meeting Abstract

    Calivo, K.; Brisley, A.; Han, J.; Arango-Hisijara, I.; Ghosh, N.; Mato, A.
    Oncology Nursing Forum (2021)

    Fulltext@MSK | Save